CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,711,000 | +5344.6% | 749,342 | +2542.6% | 0.18% | +8900.0% |
| Q1 2022 | $711,000 | -81.7% | 28,356 | -62.5% | 0.00% | -88.2% |
| Q1 2021 | $3,878,000 | -42.1% | 75,677 | -30.0% | 0.02% | -41.4% |
| Q4 2020 | $6,698,000 | +24.5% | 108,167 | +10.2% | 0.03% | +38.1% |
| Q3 2020 | $5,378,000 | +3.7% | 98,131 | +8.9% | 0.02% | -19.2% |
| Q2 2020 | $5,185,000 | +304.4% | 90,111 | +182.6% | 0.03% | +225.0% |
| Q1 2020 | $1,282,000 | +161.1% | 31,887 | -56.0% | 0.01% | +300.0% |
| Q3 2019 | $491,000 | -56.6% | 72,465 | -40.5% | 0.00% | -50.0% |
| Q2 2019 | $1,132,000 | +8.7% | 121,760 | +62.4% | 0.00% | 0.0% |
| Q1 2019 | $1,041,000 | +308.2% | 74,961 | +270.4% | 0.00% | +300.0% |
| Q3 2018 | $255,000 | – | 20,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |